Acumen Pharmaceuticals Inc Stock Ownership - Who owns Acumen Pharmaceuticals?

Insider buying vs selling

Have Acumen Pharmaceuticals Inc insiders been buying or selling?
Derek M. MeisnerChief Legal Officer Corp Sec2024-01-198,933$3.48
Daniel Joseph OconnellPresident and CEO2024-01-1915,200$3.47
Matt ZugaCFO Chief Business Officer2024-01-184,242$3.71
Eric SiemersChief Medical Officer2024-01-183,124$3.71
Russell BartonChief Operating Officer2024-01-182,833$3.73
Jeffrey L. IvesDirector2023-08-172,800$1.19
Jeffrey L. IvesDirector2023-08-172,800$6.66
Jeffrey L. IvesDirector2023-08-1739,149$6.48
Jeffrey L. IvesDirector2023-08-1739,149$0.72
Ra Capital Management LPDirector2023-07-215,161,290$7.75

1 of 1

ABOS insiders have bought more... subscribe to Premium to read more.
Net Insider Buy/Sell (L12M) Ownership

Be the first to know when ABOS insiders and whales buy or sell their stock.

ABOS Shareholders

What type of owners hold Acumen Pharmaceuticals Inc stock?
Ra Capital Management LP24.85%14,932,063$34.49MInstitution
Robert D. Hardie6.42%3,859,141$8.91MInsider
Sands Capital Ventures Discovery Fund Iii LP5.69%3,417,075$7.89MInsider
Sands Capital Ventures LLC5.69%3,417,075$7.89MInstitution
Franklin Resources Inc5.65%3,395,418$7.84MInstitution
Millennium Management LLC4.38%2,629,541$6.07MInstitution
Rock Springs Capital Management LP3.83%2,300,059$5.31MInstitution
Fmr LLC3.48%2,089,000$4.83MInstitution
Laurion Capital Management LP3.15%1,895,023$4.38MInstitution
Vanguard Group Inc2.77%1,665,058$3.85MInstitution

1 of 3

ABOS vs Biotech Stocks

TickerInst. %Insider %Net Insider (L12M)Net Insider (L3M)
ABOS72.18%16.58%Net Buying
KOD68.53%31.47%Net SellingNet Selling
ADVM40.55%59.45%Net Buying
ELEV78.86%21.14%Net SellingNet Selling

Acumen Pharmaceuticals Stock Ownership FAQ

Who owns Acumen Pharmaceuticals?

Acumen Pharmaceuticals (NASDAQ: ABOS) is owned by 72.18% institutional shareholders, 16.58% Acumen Pharmaceuticals insiders, and 11.24% retail investors. Robert D. Hardie is the largest individual Acumen Pharmaceuticals shareholder, owning 3.86M shares representing 6.42% of the company. Robert D. Hardie's Acumen Pharmaceuticals shares are currently valued at $8.91M.

If you're new to stock investing, here's how to buy Acumen Pharmaceuticals stock.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.